Treatment of invasive Candida disease and haematogenous Candida disease - expert recommendations supported by CELL

Abstract

These up-dated recommendations represent the consensus of specialists on haemato-oncology and infectious diseases on the treatment of invasive Candida disease (ICD) and haematogenous Candida disease (HCD) in patients with haematological malignity.

Keywords

• invasive Candida disease
• haematogenous Candida disease
• therapy
• haematological malignancy